Farmington's Regulatory Affairs Associates (RAA) has been awarded a contract by the National Cancer Institute (NCI) to provide regulatory consulting for up to 100 NCI drug development programs.
RAA's one-year program also has two optional continuation years. The company has worked with many cancer development drugs, including recently guiding an NCI-sponsored oral oncology drug through the FDA oversight process to clinical testing.
Every drug that the National Cancer Institute researches and develops must be approved by the FDA before becoming available to patients. RAA will direct SBIR/STTR recipients to navigate the complicated path from the laboratory to FDA approval and commercial acceptance.
Oakland County Executive L. Brooks Patterson said, "We are thrilled the National Cancer Institute awarded this important contract to a Farmington Hills company. The staff of this respected business will help 100 companies from across the country access the resources of our region, ensuring Regulatory Affairs Associates' continued growth. This contract from this most prestigious Cancer Institute is another example of how Oakland County's Medical Main Street is helping shape the future of the life science industry in Michigan and beyond. Together we are reshaping the future for Michigan."
Source: Regulatory Affairs Associates
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.